Surveillance and Epidemiology of Drug-resistant Infections Consortium

The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC) brings together a range of international experts to share expertise and take action to tackle the gaps in drug-resistant infections surveillance and epidemiology. 

SEDRIC’s aims

SEDRIC aims to transform the way countries are able to track, share and analyse information about the rise and spread of drug-resistant infections. 

Better information will speed up action and improve public health interventions, saving many lives in the process.

SEDRIC will:

  • identify the critical gaps in, and barriers to, the surveillance and epidemiology of drug-resistant infections, and how these can be overcome at a national and global level
  • provide technical expertise and knowledge to strengthen and support existing surveillance networks and activities
  • improve global co-ordination by helping countries adopt common and sustainable best practices and strategies
  • inform and shape Wellcome’s strategy for limiting the future impact of drug-resistant infections.

It began its work in January 2018 and is funded by Wellcome. 

Professor Sharon Peacock, the board's chair, explains more about what SEDRIC aims to do.

Become a member

Would you like to help shape SEDRIC’s work and be part of a global community of experts?

Applications are open to anyone who has an interest in surveillance and epidemiology of drug-resistant infections.

Read more about eligibility and apply on the SEDRIC website.

Articles and resources

SEDRIC: supporting the transition from strategy to action

Read our open letter on SEDRIC’s key role in transforming the ways that the global community are able to track, share and analyse information on antibiotic use.

Why global intelligence on superbugs is vital to stop antibiotic resistance

Read Professor Sharon Peacock's article, and watch an explanatory short film.

More information